{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:05:11Z","timestamp":1759813511655},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":98,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme","award":["06\/403\/51"],"award-info":[{"award-number":["06\/403\/51"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1111\/bjd.13729","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T16:36:47Z","timestamp":1423845407000},"page":"227-234","source":"Crossref","is-referenced-by-count":19,"title":["A randomized controlled trial to compare the safety and effectiveness of doxycycline (200\u00a0mg daily) with oral prednisolone (0\u00b75\u00a0mg\u00a0kg\u22121 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (B"],"prefix":"10.1093","volume":"173","author":[{"given":"J.R.","family":"Chalmers","sequence":"first","affiliation":[{"name":"Centre of Evidence Based Dermatology; University of Nottingham; King's Meadow Campus Lenton Lane Nottingham NG7 2NR U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Wojnarowska","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Medicine; Oxford University; Oxford OX3 7BN U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kirtschig","sequence":"additional","affiliation":[{"name":"Centre of Evidence Based Dermatology; University of Nottingham; King's Meadow Campus Lenton Lane Nottingham NG7 2NR U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Nunn","sequence":"additional","affiliation":[{"name":"Medical Research Council Clinical Trials Unit; Aviation House 125 Kingsway London WC2B 6NH U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Bratton","sequence":"additional","affiliation":[{"name":"Medical Research Council Clinical Trials Unit; Aviation House 125 Kingsway London WC2B 6NH U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mason","sequence":"additional","affiliation":[{"name":"School for Medicine; Pharmacy and Health; Wolfson Research Institute; Durham University; Stockton on Tees TS17 6BH U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.A.","family":"Foster","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit; Nottingham Health Science Partners; C Floor South Block Nottingham U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Whitham","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit; Nottingham Health Science Partners; C Floor South Block Nottingham U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C.","family":"Williams","sequence":"additional","affiliation":[{"name":"Centre of Evidence Based Dermatology; University of Nottingham; King's Meadow Campus Lenton Lane Nottingham NG7 2NR U.K"},{"name":"Dermatology Department; Queen's Medical Centre; University of Nottingham; Nottingham NG7 2UH U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the BLISTER study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,5,26]]},"reference":[{"key":"10.1111\/bjd.13729-BIB0001|bjd13729-cit-0001","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/bjd.13729-BIB0002|bjd13729-cit-0002","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/bjd.13729-BIB0003|bjd13729-cit-0003","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0190-9622(92)70085-T","article-title":"Lack of predictive factors for the clinical course of bullous pemphigoid","volume":"26","author":"Venning","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13729-BIB0004|bjd13729-cit-0004","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2133.1979.tb11881.x","article-title":"The events leading to the death of patients with pemphigus and pemphigoid","volume":"101","author":"Savin","year":"1979","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13729-BIB0005|bjd13729-cit-0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0738-081X(87)90049-6","article-title":"Death in bullous pemphigoid","volume":"5","author":"Savin","year":"1987","journal-title":"Clin Dermatol"},{"key":"10.1111\/bjd.13729-BIB0006|bjd13729-cit-0006","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13729-BIB0007|bjd13729-cit-0007","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000106574","article-title":"French Study Group of Bullous Diseases. Neurological disorders in patients with bullous pemphigoid","volume":"215","author":"Cordel","year":"2007","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13729-BIB0008|bjd13729-cit-0008","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/archdermatol.2010.322","article-title":"The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study","volume":"146","author":"Taghipour","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13729-BIB0009|bjd13729-cit-0009","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case-control study","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13729-BIB0010|bjd13729-cit-0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/2013.jamadermatol.376","article-title":"The associations between bullous pemphigoid and drug use: a UK case-control study","volume":"149","author":"Lloyd-Lavery","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1111\/bjd.13729-BIB0011|bjd13729-cit-0011","first-page":"CD002292","article-title":"Interventions for bullous pemphigoid","author":"Khumalo","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1111\/bjd.13729-BIB0012|bjd13729-cit-0012","first-page":"CD002292","article-title":"Interventions for bullous pemphigoid","author":"Kirtschig","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.13729-BIB0013|bjd13729-cit-0013","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.13729-BIB0014|bjd13729-cit-0014","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"Comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study","volume":"129","author":"Joly","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13729-BIB0015|bjd13729-cit-0015","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13729-BIB0016|bjd13729-cit-0016","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archderm.1986.01660180076019","article-title":"The treatment of bullous pemphigoid with tetracycline and niacinamide. A preliminary report","volume":"122","author":"Berk","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13729-BIB0017|bjd13729-cit-0017","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2133.1995.tb02498.x","article-title":"Bullous pemphigoid successfully controlled by tetracycline and nicotinamide","volume":"133","author":"Kolbach","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13729-BIB0018|bjd13729-cit-0018","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0190-9622(93)70013-J","article-title":"Treatment of generalized bullous pemphigoid with oral tetracycline","volume":"28","author":"Thomas","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13729-BIB0019|bjd13729-cit-0019","first-page":"327","article-title":"Tetracycline and nicotinamide for the treatment of bullous pemphigoid: our experience in Singapore","volume":"41","author":"Goon","year":"2000","journal-title":"Singapore Med J"},{"key":"10.1111\/bjd.13729-BIB0020|bjd13729-cit-0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ced.12042","article-title":"The approach of dermatologists in the UK to the treatment of bullous pemphigoid: results of a national survey","volume":"38","author":"Taghipour","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.13729-BIB0021|bjd13729-cit-0021","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1745-6215-13-50","article-title":"The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study","volume":"13","author":"Bratton","year":"2012","journal-title":"Trials"},{"key":"10.1111\/bjd.13729-BIB0022|bjd13729-cit-0022","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/sim.1425","article-title":"Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics","volume":"22","author":"D'Agostino","year":"2003","journal-title":"Stat Med"},{"key":"10.1111\/bjd.13729-BIB0023|bjd13729-cit-0023","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/1740774512453220","article-title":"When inferiority meets non-inferiority: implications for interim analyses","volume":"9","author":"Bratton","year":"2012","journal-title":"Clin Trials"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13729","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13729\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:14:11Z","timestamp":1676384051000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/173\/1\/227\/6616895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,26]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13729","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"type":"print","value":"0007-0963"}],"subject":[],"published":{"date-parts":[[2015,5,26]]}}}